Tudor Investment Corp ET AL Acquires Shares of 75,134 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Tudor Investment Corp ET AL purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 75,134 shares of the medical instruments supplier's stock, valued at approximately $1,426,000.

Other large investors also recently added to or reduced their stakes in the company. Riverview Trust Co bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. MassMutual Private Wealth & Trust FSB lifted its holdings in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,232 shares during the last quarter. UMB Bank n.a. raised its stake in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after buying an additional 1,568 shares during the last quarter. Finally, Quarry LP raised its stake in DENTSPLY SIRONA by 25.7% during the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after buying an additional 780 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Up 16.3 %

XRAY stock traded up $2.23 during trading on Thursday, hitting $15.91. 9,522,299 shares of the company's stock were exchanged, compared to its average volume of 2,978,610. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $28.69. The stock has a market capitalization of $3.17 billion, a price-to-earnings ratio of -7.69, a PEG ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The business has a 50-day moving average price of $14.36 and a two-hundred day moving average price of $17.69.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same period in the prior year, the business posted $0.42 EPS. The company's revenue for the quarter was down 7.8% on a year-over-year basis. As a group, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.02%. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.52% of the stock is owned by insiders.

Wall Street Analyst Weigh In

XRAY has been the topic of several recent analyst reports. Piper Sandler dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 30th. Mizuho dropped their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research note on Tuesday, April 15th. Jefferies Financial Group cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their price objective for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Finally, Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Twelve research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of "Hold" and an average price target of $20.45.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.